3.5FR DUAL-LUMEN UVC CATH
Received Nov 24, 2021 · Event occurred Nov 3, 2021
Report 3009211636-2021-00770 · MDR key 12868823
Device
Generic name
Catheter, Umbilical Artery
Manufacturer
Cardinal HealthModel number
8888160531Catalog number
8888160531
Lot number
2111100135
Product problems
- Fluid/Blood Leak
- Fluid/Blood Leak
Patient
Unknown
- No Clinical Signs, Symptoms or Conditions
- No Clinical Signs, Symptoms or Conditions
Narrative
Additional Manufacturer Narrative
INVESTIGATION CONCLUSION: THE CUSTOMER REPORTED THAT THERE WAS A LEAKING UVC LINE. ADDITIONAL INFORMATION PROVIDED STATED LEAKING WAS NOTED UPON INSERTION OF THE UMBILICAL VENOUS CATHETER. THE LINE HAD JUST BEEN SECURED AND AMINO ACIDS/DEXTROSE SOLUTION HAD COMMENCED INFUSING WHEN THE INSERTER NOTED A YELLOW TINGED FLUID LEAKING FROM THE UMBILICUS. THEY ADDED ANOTHER PURSE STRING SUTURE AS THE UMBILICAL VEIN WAS RELATIVELY LARGE, BUT THE LEAKING CONTINUED. THEY ARE CONFIDENT THAT NO SUTURE NEEDLE SNAGGED/CUT THE LINE AT ANY POINT IN TIME. THE LEAK WAS OBSERVED AT THE 4 CM MARK ON THE CATHETER BODY. IT OCCURS ONLY WHEN FLUSHING THE SECONDARY (BLUE) LUMEN. THE STANDARD PRACTICE IS TO CLEAN THE UMBILICAL CORD WITH EITHER 2% CHG WITH 70% ALCOHOL OR 0.5% CHG WITH 70% ALCOHOL AND FOR THE AREA TO BE COMPLETELY DRY BEFORE INSERTION. THE DEVICE SHOULD BE SECURED WITH 2.0 SILK SUTURES AND H-TAPE TO TAPE THE LINE TO THE PATIENT. AFTER REMOVAL. THE DEVICE WAS REPLACED WITH ANOTHER DOUBLE LUMEN UMBILICAL VENOUS CATHETER INTO THE UMBILICAL VEIN. THERE WAS NO PATIENT INJURY REPORTED. A DEVICE HISTORY RECORD (DHR) REVIEW WAS PERFORMED AND REVEALED NO DISCREPANCIES THAT MAY HAVE CONTRIBUTED TO A COMPLAINT OF THIS FAILURE MODE. ALL QUALITY ASSURANCE TESTING PERFORMED DURING MANUFACTURING WAS ACCEPTABLE. IN ADDITION, ALL DHRS ARE REVIEWED FOR ACCURACY PRIOR TO PRODUCT RELEASE. LOT AND FAILURE MODE TRENDING WERE REVIEWED, AND NO RELATED ADVERSE TRENDS WERE IDENTIFIED. THE REPORTED USED PRODUCT WAS RETURNED FOR EVALUATION. VISUAL INSPECTION OF THE RETURNED PRODUCT IDENTIFIED BLOOD RESIDUE ON THE CATHETER AND TWO ADAPTERS WERE PRESENT THAT DO NOT BELONG TO THE ORIGINAL PRODUCT. FUNCTIONAL TESTING PERFORMED, VIA AN UNDERWATER TEST, AND CONFIRMED THE REPORTED PRODUCT FAILURE. A LEAK WAS IDENTIFIED AS WELL AS AN IRREGULAR CUT ON THE TUBING. THE INSTRUCTION FOR USE (IFU) STATES ¿THE CATHETER LUMEN OF CATHETER SHAFT SHOULD BE FLUSHED AND FILLED WITH HEPARINIZED SALINE PER HOSPITAL PROTOCOL. THE CATHETER MAY BE GRASPED WITH A SMOOTH FORCEPS OF FINGERTIPS AND INSERTED INTO THE LUMEN OF THE DILATED VESSEL. CATHETER LUMEN SHOULD BE OCCLUDED WITH SALINE VIA INTERMITTENT INFUSION CAPS OF LUER-LOCK SYRINGES DURING INSERTION TO AVOID AIR EMBOLI.¿ THE LIKELY CAUSE OF THE CONFIRMED PRODUCT FAILURE IS INADEQUATE HANDLING. THE QUALITY ASSURANCE REVIEW OF THE VISUAL, PHYSICAL, AND DIMENSIONAL EVALUATION RESULTS INDICATED THAT THE PRODUCT MET SPECIFICATION REQUIREMENTS. IT MUST BE NOTED THAT IN-PROCESS CONTROLS (SUCH AS PERSONNEL TRAINING, INCOMING QUALITY ACCEPTANCE TESTING FOR RAW MATERIAL, 100% IN PROCESS VISUAL INSPECTION AND VISUAL ACCEPTANCE SAMPLING ARE PERFORMED IN THE PLANT) ARE IN PLACE TO PREVENT NONCONFORMING PRODUCT FROM LEAVING THE MANUFACTURING OPERATIONS. ADDITIONAL ACTION WILL NOT BE TAKEN AT THIS TIME. THIS COMPLAINT WILL BE USED FOR TRACKING AND TRENDING PURPOSES.
Description of Event or Problem
THE CUSTOMER REPORTED THAT THERE WAS A LEAKING UVC LINE. PER ADDITIONAL INFORMATION RECEIVED, LEAKING WAS NOTED UPON INSERTION OF THE UMBILICAL VENOUS CATHETER. THE LINE HAD JUST BEEN SECURED AND AMINO ACIDS/DEXTROSE SOLUTION HAD COMMENCED INFUSING WHEN THE INSERTER NOTED A YELLOW TINGED FLUID LEAKING FROM THE UMBILICUS. THEY ADDED ANOTHER PURSE STRING SUTURE AS THE UMBILICAL VEIN WAS RELATIVELY LARGE BUT THE LEAKING CONTINUED. THEY ARE CONFIDENT THAT NO SUTURE NEEDLE SNAGGED/CUT THE LINE AT ANY POINT IN TIME. THE LEAK WAS OBSERVED AT THE 4 CM MARK ON THE CATHETER BODY. IT OCCURS ONLY WHEN FLUSHING THE SECONDARY (BLUE) LUMEN. THE STANDARD PRACTICE IS TO CLEAN THE UMBILICAL CORD WITH EITHER 2% CHG WITH 70% ALCOHOL OR 0.5% CHG WITH 70% ALCOHOL AND FOR THE AREA TO BE COMPLETELY DRY BEFORE INSERTION. THE DEVICE SHOULD BE SECURED WITH 2.0 SILK SUTURES AND H-TAPE TO TAPE THE LINE TO THE PATIENT. AFTER REMOVAL. THE DEVICE WAS REPLACED WITH ANOTHER DOUBLE LUMEN UMBILICAL VENOUS CATHETER INTO THE UMBILICAL VEIN. THERE WAS NO PATIENT INJURY REPORTED.
Additional Manufacturer Narrative
THE INCIDENT SAMPLE HAS BEEN REQUESTED BUT TO DATE HAS NOT BEEN RECEIVED FOR EVALUATION. IF THE SAMPLE IS RECEIVED, OR IF ADDITIONAL INFORMATION PERTINENT TO THE INCIDENT IS OBTAINED A FOLLOW-UP REPORT WILL BE SUBMITTED. AS PART OF OUR MANUFACTURING PROCESS, ALL DEVICE HISTORY RECORDS ARE REVIEWED AND APPROVED BY QUALITY, PRIOR TO RELEASE OF PRODUCT.